A Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 in Obese and High Risk Overweight Subjects.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 in Obese and High Risk Overweight Subjects.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2010

At a glance

  • Drugs Ibipinabant (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 20 Mar 2008 Status changed from in progress to completed, in accordance with clinicaltrials.gov.
    • 15 Jun 2007 Status changed from recruiting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top